AGN-151597 (Formerly RST-001) Phase I/II Trial for Advanced Retinitis Pigmentosa

Completed · Phase 1/Phase 2

Conditions studied: Advanced Retinitis Pigmentosa

In brief

All participants in phase 1 and phase 2a had hand motion visual acuity or worse. If efficacy was demonstrated from phase 1, better vision subjects could be enrolled; however, efficacy was not demonstrated.

Key facts

Study ID

NCT02556736

Run by

AbbVie

People needed

14

Starts

2015-12-14

Expected to finish

2024-10-21

Last updated by the study team

2026-01-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants must meet all of the following criteria.
• Age >= 18 years.
• Signed and dated written informed consent obtained from the patient.
• Ability to comply with testing and all protocol tests.

You may not qualify if…

• Any one of the following will exclude patients from being enrolled into the study:
• Unable or unwilling to meet requirements of the study.
• Participation in a clinical study (ocular or non-ocular) with an investigational drug, agent or therapy in the past six months.

Where it is running

• University of California San Francisco - Mission Bay /ID# 235717 — San Francisco, California, United States
• Cincinnati Eye Institute- Edgewood /ID# 236713 — Edgewood, Kentucky, United States
• Duke Eye Center /ID# 235715 — Durham, North Carolina, United States
• Retina Foundation of the Southwest /ID# 235199 — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.